Effect of Quadratus Lumborum Block in C/S
Comparison of Ultrasound Guided Quadratus Lumborum Block-2 and Quadratus Lumborum Block-3 for Postoperative Pain in Cesarean Section
1 other identifier
interventional
143
1 country
1
Brief Summary
to compare postoperative analgesic effects of USG guided QLB-2 and QLB-3 blocks after C/S. We hypothesized that QLB-3 may be more effective for pain relieving than QLB-2 after C/S.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Jul 2017
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2018
CompletedFirst Submitted
Initial submission to the registry
January 24, 2021
CompletedFirst Posted
Study publicly available on registry
February 2, 2021
CompletedFebruary 2, 2021
January 1, 2021
10 months
January 24, 2021
January 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Assesment of postoperative pain
measure of the visual analog scale at rest and dynamic after surgery
during 24 hour after surgery
Secondary Outcomes (1)
need of analgesic
during 24 hour after surgery
Study Arms (2)
quadratus lumborum-2
ACTIVE COMPARATORquadratus lumborum-3
ACTIVE COMPARATORInterventions
Administering local aneshtetic agent with a block needle using the in-plane technique, bilaterally. Lumbar interfascial triangle, where the middle lumbar fascia joins the deep lamina of the posterior layer on the lateral border of the erector spinae was targeted as the optimal point of injection.
Eligibility Criteria
You may qualify if:
- pregnancy with a gestation of 37-41 weeks parturients who were scheduled for elective cesarean delivery under general anesthesia
- obtained patients informed consent
You may not qualify if:
- inability to comprehend
- bleeding diathesis
- allergy to the study agents
- localized infection
- block failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Healt Science University Bursa Training and Research Hospita
Bursa, Yildirim, 16310, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical doctor
Study Record Dates
First Submitted
January 24, 2021
First Posted
February 2, 2021
Study Start
July 15, 2017
Primary Completion
May 15, 2018
Study Completion
August 15, 2018
Last Updated
February 2, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share